Our analyses showed that VAT ZAG expression levels were higher in patients with morbid obesity and low IR compared with those presenting high IR, and VAT ZAG expression levels were independently related to insulin, homeostatic model assessment of insulin resistance (HOMA-IR), and adiponectin [12]. The gene discussed is AZGP1; the disease is morbid obesity.